Table I.
Associations between BCAT1 expression and clinicopathologic features of patients with hepatocellular carcinoma.
BCAT1 protein, n | ||||
---|---|---|---|---|
Characteristics | n | High | Low | P-value |
Gender | 0.787 | |||
Female | 18 | 8 | 10 | |
Male | 56 | 29 | 27 | |
Age, years | 1.000 | |||
≤45 | 17 | 9 | 8 | |
>45 | 57 | 28 | 29 | |
HBsAg status | 0.674 | |||
Negative | 6 | 4 | 2 | |
Positive | 68 | 33 | 35 | |
Cirrhosis | 0.754 | |||
No | 12 | 7 | 5 | |
Yes | 62 | 30 | 32 | |
AFP, µg/l | 0.634 | |||
≤400 | 29 | 13 | 16 | |
>400 | 45 | 24 | 21 | |
Tumor size, cm | 0.087 | |||
≤5 | 26 | 17 | 9 | |
>5 | 48 | 20 | 28 | |
Tumor number | 0.003a | |||
Single | 47 | 17 | 30 | |
Multiple | 27 | 20 | 7 | |
Tumor capsule | 0.074 | |||
Complete | 52 | 30 | 22 | |
Incomplete | 22 | 7 | 15 | |
Vascular invasion | 0.017a | |||
No | 54 | 22 | 32 | |
Yes | 20 | 15 | 5 | |
Edmondson grade | 0.027a | |||
I/II | 48 | 19 | 29 | |
III/IV | 26 | 18 | 8 | |
TNM stage | 0.017a | |||
I+II | 45 | 17 | 28 | |
III+IV | 29 | 20 | 9 |
P<0.05. BCAT1, branched-chain amino acid transaminase 1; HbsAg, hepatitis B surface antigen; AFP, α-fetoprotein; TNM, tumor-node-metastasis.